http://terminology.hl7.org/CodeSystem/v2-0292|2.9
name
v2.0292
v2.0292
package
hl7.fhir.r4.core@4.0.1
hl7.fhir.r4.core@4.0.1
content
complete
complete
status
active
active
v2 Vaccines Administered
FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered)
| code | display | definition | hierarchy |
|---|---|---|---|
| 01 | DTP | ||
| 02 | OPV | ||
| 03 | MMR | ||
| 04 | M/R | ||
| 05 | measles | ||
| 06 | rubella | ||
| 07 | mumps | ||
| 08 | Hep B, adolescent or pediatric | ||
| 09 | Td (adult) | ||
| 10 | IPV | ||
| 100 | pneumococcal conjugate | ||
| 101 | typhoid, ViCPs | ||
| 102 | DTP-Hib-Hep B | ||
| 103 | meningococcal C conjugate | ||
| 104 | Hep A-Hep B | ||
| 105 | vaccinia (smallpox) diluted | ||
| 106 | DTaP, 5 pertussis antigens6 | ||
| 107 | DTaP, NOS | ||
| 108 | meningococcal, NOS | ||
| 109 | pneumococcal, NOS | ||
| 11 | pertussis | ||
| 110 | DTaP-Hep B-IPV | ||
| 111 | influenza, live, intranasal | ||
| 112 | tetanus toxoid, NOS | ||
| 113 | Td (adult) | ||
| 114 | meningococcal A,C,Y,W-135 diphtheria conjugate | ||
| 115 | Tdap | ||
| 116 | rotavirus, pentavalent | ||
| 117 | VZIG (IND) | ||
| 118 | HPV, bivalent | ||
| 119 | rotavirus, monovalent | ||
| 12 | diphtheria antitoxin | ||
| 120 | DTaP-Hib-IPV | ||
| 121 | zoster | ||
| 122 | rotavirus, NOS1 | ||
| 13 | TIG | ||
| 14 | IG, NOS | ||
| 15 | influenza, split (incl. purified surface antigen) | ||
| 16 | influenza, whole | ||
| 17 | Hib, NOS | ||
| 18 | rabies, intramuscular injection | ||
| 19 | BCG | ||
| 20 | DTaP | ||
| 21 | varicella | ||
| 22 | DTP-Hib | ||
| 23 | plague | ||
| 24 | anthrax | ||
| 25 | typhoid, oral | ||
| 26 | cholera | ||
| 27 | botulinum antitoxin | ||
| 28 | DT (pediatric) | ||
| 29 | CMVIG | ||
| 30 | HBIG | ||
| 31 | Hep A, pediatric, NOS | ||
| 32 | meningococcal | ||
| 33 | pneumococcal | ||
| 34 | RIG | ||
| 35 | tetanus toxoid | ||
| 36 | VZIG | ||
| 37 | yellow fever | ||
| 38 | rubella/mumps | ||
| 39 | Japanese encephalitis | ||
| 40 | rabies, intradermal injection | ||
| 41 | typhoid, parenteral | ||
| 42 | Hep B, adolescent/high risk infant2 | ||
| 43 | Hep B, adult4 | ||
| 44 | Hep B, dialysis | ||
| 45 | Hep B, NOS | ||
| 46 | Hib (PRP-D) | ||
| 47 | Hib (HbOC) | ||
| 48 | Hib (PRP-T) | ||
| 49 | Hib (PRP-OMP) | ||
| 50 | DTaP-Hib | ||
| 51 | Hib-Hep B | ||
| 52 | Hep A, adult | ||
| 53 | typhoid, parenteral, AKD (U.S. military) | ||
| 54 | adenovirus, type 4 | ||
| 55 | adenovirus, type 7 | ||
| 56 | dengue fever | ||
| 57 | hantavirus | ||
| 58 | Hep C | ||
| 59 | Hep E | ||
| 60 | herpes simplex 2 | ||
| 61 | HIV | ||
| 62 | HPV, quadrivalent | ||
| 63 | Junin virus | ||
| 64 | leishmaniasis | ||
| 65 | leprosy | ||
| 66 | Lyme disease | ||
| 67 | malaria | ||
| 68 | melanoma | ||
| 69 | parainfluenza-3 | ||
| 70 | Q fever | ||
| 71 | RSV-IGIV | ||
| 72 | rheumatic fever | ||
| 73 | Rift Valley fever | ||
| 74 | rotavirus, tetravalent | ||
| 75 | vaccinia (smallpox) | ||
| 76 | Staphylococcus bacterio lysate | ||
| 77 | tick-borne encephalitis | ||
| 78 | tularemia vaccine | ||
| 79 | vaccinia immune globulin | ||
| 80 | VEE, live | ||
| 81 | VEE, inactivated | ||
| 82 | adenovirus, NOS1 | ||
| 83 | Hep A, ped/adol, 2 dose | ||
| 84 | Hep A, ped/adol, 3 dose | ||
| 85 | Hep A, NOS | ||
| 86 | IG | ||
| 87 | IGIV | ||
| 88 | influenza, NOS | ||
| 89 | polio, NOS | ||
| 90 | rabies, NOS | ||
| 91 | typhoid, NOS | ||
| 92 | VEE, NOS | ||
| 93 | RSV-MAb | ||
| 94 | MMRV | ||
| 95 | TST-OT tine test | ||
| 96 | TST-PPD intradermal | ||
| 97 | TST-PPD tine test | ||
| 98 | TST, NOS | ||
| 99 | RESERVED - do not use3 | ||
| 998 | no vaccine administered5 | ||
| 999 | unknown |